Merit Medical Systems: Q4 Earnings Insights

Shares of Merit Medical Systems MMSI were flat in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share increased 35.00% year over year to $0.54, which beat the estimate of $0.43.

Revenue of $258,004,000 up by 0.03% year over year, which beat the estimate of $250,450,000.

Outlook

The upcoming fiscal year's EPS expected to be between $1.84 and $1.98.

The upcoming fiscal year's revenue expected to be between $990,000,000 and $1,010,000,000.

Conference Call Details

Date: Feb 24, 2021

Time: 05:00 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/cxg5cavx

Technicals

Company's 52-week high was at $61.23

52-week low: $25.18

Price action over last quarter: Up 9.44%

Company Profile

Merit Medical Systems, Inc. is a South Jordan, Utah, based medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm currently reports through two overarching units, Cardiovascular (96% of 2018 revenue) and Endoscopy (4%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for approximately 55% of 2018 revenue and international sales making up the remaining 45%.